About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Dbttm1Geh
targeted mutation 1, Gregg E Homanics
MGI:3704091
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Dbttm1Geh/Dbttm1Geh involves: 129S1/Sv * 129X1/SvJ * C57BL/6J MGI:3704912
cx2
Dbttm1Geh/Dbttm1Geh
Tg(tetO-DBT)A1Geh/0
Tg(Cebpb-tTA)5Bjd/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI MGI:3704913
cx3
Dbttm1Geh/Dbttm1Geh
Tg(tetO-DBT)525AGeh/0
Tg(Cebpb-tTA)5Bjd/0
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI MGI:3704920


Genotype
MGI:3704912
hm1
Allelic
Composition
Dbttm1Geh/Dbttm1Geh
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dbttm1Geh mutation (1 available); any Dbt mutation (39 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• on day 1 after birth, homozygotes become moribund and almost all die within 72 hours of birth; one pup lived to P13

behavior/neurological
• on first day after birth, homozygotes become lethargic

homeostasis/metabolism
• homozygotes have nearly 3-fold increased levels of branched-chain amino acids (BCAA, sum of leucine + isoleucine + valine) in the blood compared to wild-type littermates
• BCAA/alanine ratio is 6-fold higher than in wild-type or heterozygotes
• blood levels of alanine are markedly lower than in wild-type or heterozygous mice
• blood levels of glutamate are markedly lower than in wild-type or heterozygous mice
• blood levels of glutamine are markedly lower than in wild-type or heterozygous mice
• homozygotes have nearly 3-fold increased levels of BCAA in urine compared to wild-type littermates

respiratory system
• on first day after birth, homozygotes display gasping

renal/urinary system
• homozygotes have nearly 3-fold increased levels of BCAA in urine compared to wild-type littermates

integument
• on first day after birth, homozygotes are pale

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
maple syrup urine disease DOID:9269 OMIM:246900
OMIM:248600
OMIM:615135
J:119973




Genotype
MGI:3704913
cx2
Allelic
Composition
Dbttm1Geh/Dbttm1Geh
Tg(tetO-DBT)A1Geh/0
Tg(Cebpb-tTA)5Bjd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dbttm1Geh mutation (1 available); any Dbt mutation (39 available)
Tg(Cebpb-tTA)5Bjd mutation (3 available)
Tg(tetO-DBT)A1Geh mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• transgenic mice survival is only ~16 weeks, when mice become moribund and are sacrificed
• approximately 4% of pups surviving to weaning have this genotype, compared to a theoretical survival rate or 14%, indicating partial rescue of the Dbttm1Geh phenotype

homeostasis/metabolism
• blood levels of alanine, glutamate, and glutamine are reduced compared to controls, but greater than in Dbttm1Geh homozygous mice
• BCAA/alanine (BCAA -branched-chain amino acids - leucine + isoleucine + valine) values are intermediate between controls and Dbt-null mice between 4-7 weeks of age
• levels of branched-chain keto acid dehydrogenase (BCKDH) activity are only 5-6% of controls levels, despite nearly equal protein levels, indicating suboptimal BCKDH activity of protein assembled with human E2

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
maple syrup urine disease DOID:9269 OMIM:246900
OMIM:248600
OMIM:615135
J:119973




Genotype
MGI:3704920
cx3
Allelic
Composition
Dbttm1Geh/Dbttm1Geh
Tg(tetO-DBT)525AGeh/0
Tg(Cebpb-tTA)5Bjd/0
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB * NMRI
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Dbttm1Geh mutation (1 available); any Dbt mutation (39 available)
Tg(Cebpb-tTA)5Bjd mutation (3 available)
Tg(tetO-DBT)525AGeh mutation (0 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• only 12% (2/16) transgenic mice survive to 20 weeks; two surviving mice live to 40 and 60 weeks, respectively
• approximately 11% of pups surviving to weaning have this genotype, compared to a theoretical survival rate or 14%, indicating high degree of rescue of the Dbt-deficient phenotype

homeostasis/metabolism
• blood levels of glutamate are reduced compared to controls, but greater than in Dbttm1Geh homozygotes
• BCAA/alanine (BCAA -branched-chain amino acids - leucine + isoleucine + valine) values are intermediate between controls and Dbttm1Geh homozygotes between 4-10 weeks of age

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
maple syrup urine disease DOID:9269 OMIM:246900
OMIM:248600
OMIM:615135
J:119973





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory